Home  /  Resource Library  /  Relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group

Relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group

Key points – Patients with relapsed or refractory nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) have a favorable overall prognosis. Treatment of relapsed or refractory NLPHL should be chosen individually.